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and vesical veins, as well as in the 
liver and the portal system.
In a more comprehensive study 
(9), Bulinus snails were found in all 
of Corsica’s coastal rivers, except for 
those in the northwestern-most part of 
the island. However,  of the 55 bod-
ies of water where Bulinus snails were 
found, only 1 contained gastropods 
with Schistosoma cercariae, and re-
sults of a search for blood flukes in 220 
small rodents (known for being sus-
ceptible to S. bovis and captured near 
bodies of water where Bulinus snails 
had been observed) were negative. 
We have found no other docu-
mentation on bovine schistosomiasis 
in Corsica between 1966 and the pres-
ent time. Has this disease disappeared 
since the 1960s? Is it still present as an 
enzootic disease with silent transmis-
sion? It should be noted that the disease 
produces few or no clinical signs and 
that slaughterhouse detection requires 
dissection of the circulatory system of 
the abdominal cavity. In any case, the 
discovery of human cases of schisto-
somiasis proves that a human–Bulinus 
parasitic cycle exists in Corsica, and 
therefore an animal–Bulinus cycle may 
exist as well. For the sake of scientific 
interest, an investigation into the pres-
ence of S. bovis in ruminants in Cor-
sica would be worthwhile. Moreover, 
the fact that both Schistosoma species 
use the same intermediate host, Bulinus 
contortus snails, could cause problems 
with differential diagnosis.
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HIV-Associated  
Disseminated  
Emmonsiosis,  
Johannesburg, 
South Africa
To the Editor: Emmonsia spp., 
dimorphic fungi found worldwide, 
cause disease mainly among lower- 
order mammals (1). Although emmon-
sia rarely infect humans, the fungi can 
cause localized granulomatous pul-
monary disease (adiaspiromycosis) in 
immunocompetent persons (1–4). Be-
fore 2013, no association was known 
between emmonsia and HIV, and there 
was no indication that emmonsia were 
endemic to sub-Saharan Africa.
In 2013 a novel Emmonsia sp. 
that is closely related to E. pasteuriana 
was described. The fungus caused dis-
seminated disease in 13 HIV-infected 
persons in South Africa (12 in Cape 
Town, 1 in Bloemfontein) (5). Two 
additional cases of disseminated em-
monsiosis caused by this novel species 
were identified in HIV-uninfected per-
sons (1 immunocompetent, the other 
immunosuppressed for renal trans-
plantation) in Cape Town (6). Because 
these cases clustered geographically, it 
was suggested that this novel Emmon-
sia sp. occupies a microenvironment 
around Cape Town (7). We report 3 
additional cases of disseminated em-
monsiosis from Johannesburg, South 
Africa, 403 km from Bloemfontein 
and 1,400 km from Cape Town. All 
patients were HIV-infected and re-
ported no travel to Bloemfontein or 
Cape Town.
The 3 patients were admitted to 
Helen Joseph Hospital between Au-
gust 2012 and August 2014; all pa-
tients were male and had CD4 counts 
of ≤5 cells/µL at admission. Patient 1 
had never received antiretroviral thera-
py; patients 2 and 3 had defaulted anti-
retroviral treatment for several months 
before admission. All patients had 
disseminated skin rash, pneumonia, 
anemia, and substantial weight loss; 
chest radiographs suggested pulmo-
nary tuberculosis. The rash appeared 
as disseminated hyperpigmented scaly 
papules and plaques (online Techni-
cal Appendix Figure 1, http://wwwnc.
cdc.gov/EID/article/20/12/14-0902-
Techapp1.pdf). Patients 1 and 2 also 
had diarrhea and exhibited delirium. 
Laboratory investigations for pa-
tient 1 showed normocytic anemia, 
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hyponatremia, renal insufficiency, and 
elevated liver enzyme levels. Patients 
2 and 3 had pancytopenia, hyponatre-
mia, metabolic acidosis, and elevated 
liver enzyme levels. Lumbar puncture 
results were unremarkable for patients 
1 and 3; patient 2 had normal lumbar 
puncture results during a previous ad-
mission (online Technical Appendix 
Table 1). Automated laboratory identi-
fication systems initially misidentified 
the Emmonsia sp. on blood culture as 
Trichosporon spp. (patients 1 and 3) 
and Histoplasma capsulatum (patient 
2). Co-infection with Mycobacterium 
avium (patients 1 and 2) and M. tu-
berculosis (patient 2) was observed 
(online Technical Appendix Table 2). 
Subsequent histologic examination 
of skin biopsy specimens from all pa-
tients showed granulomas and yeast-
like organisms.
Antifungal drug therapy con-
sisted of fluconazole for patient 1 
and conventional amphotericin B for 
patients 2 and 3; itraconazole was 
co-administered to patient 2 (online 
Technical Appendix Table 3). Clinical 
and biochemical parameters improved 
for all patients during the first 2 weeks 
of hospitalization. However, hospital-
acquired pneumonia developed in 
patient 1, who subsequently died on 
hospitalization day 21, and patient 2 
died of an unknown cause on day 17. 
Permission for autopsy was not grant-
ed for either patient. At the time of this 
report, patient 3 was recovering well.
The fungal isolates were not iden-
tified molecularly before patients 1 and 
2 died. Sequencing of the ribosomal 
DNA internal transcribed spacer region 
of isolates from all 3 patients showed 
97%–99% homology with the previ-
ously described novel Emmonsia sp. 
(GenBank accession nos. KM199781–
83 and KM492927) (5). At admission, 
clinical features for patients in our 
study were similar to those for patients 
with the previously reported cases of 
HIV-associated emmonsiosis (5): all 
patients had rash, anemia, low CD4 
count, abnormal liver enzyme levels, 
and chest radiographs compatible with 
pulmonary tuberculosis.
The patients in our study received 
an initial misdiagnosis. Kenyon et al. 
(5) also encountered diagnostic am-
biguity in invasive fungal infection 
cases: over an 8-year period in South 
Africa, 39 cases were diagnosed as 
histoplasmosis on the basis of histo-
logic findings, and only 1 was con-
firmed by using molecular techniques. 
Because laboratory services in Africa 
are generally weak (8), this trend of 
misdiagnosis could continue. The high 
death rate among patients with HIV-
associated emmonsiosis (31%, 5/16 
patients) may partly be explained by 
misdiagnoses (5), and it also raises 
questions regarding optimal treatment. 
Amphotericin B will likely remain the 
optimal empiric induction therapy 
for suspected cases of disseminated 
fungal infection among HIV-infected 
persons in sub-Saharan Africa, given 
the phylogenetic proximity of Em-
monsia spp. to Histoplasma spp., the 
antifungal minimum inhibitory con-
centrations of emmonsia reported thus 
far (5), and the potential for labora-
tory misdiagnosis of fungal infection 
cases. Supplementary itraconazole 
may be beneficial if dimorphic fungal 
infection, specifically emmonsia, is 
clinically suspected. Regardless, early 
confirmatory diagnoses based on cul-
ture and histopathologic results should 
be aggressively pursued.
Although HIV-associated em-
monsiosis was suggested to be geo-
graphically isolated to the Western 
Cape Province, South Africa (7), the 
ecologic niche occupied by this nov-
el Emmonsia sp. probably extends 
throughout southern Africa. Of the 13 
previously reported patients (5), 12 
lived near Cape Town (Western Cape 
Province) and 1 lived in Bloemfontein 
(Free State Province; in the center of 
the country) at the time of diagnosis. 
The 3 additional patients reported in 
our study resided in Johannesburg, a 
geographic setting distinctly separate 
from the other locations. A region-
wide surveillance program is needed 
to enhance disease identification with-
in South Africa and to determine the 
environmental presence of this organ-
ism beyond South Africa’s borders.
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Ecosystem Effects 
of Variant Rabbit 
Hemorrhagic  
Disease Virus,  
Iberian Peninsula
To the Editor: In this investiga-
tion, we found evidence for the ap-
parent effects that a new variant of 
the rabbit hemorrhagic disease virus 
(RHDV) is having on native wild Eu-
ropean rabbit (Oryctolagus cuniculus) 
populations on the Iberian Peninsula, 
and how this virus could threaten the 
conservation of endangered predators.
Historically, European rabbits 
were extremely abundant on the Ibe-
rian Peninsula, which is in their native 
range. However, during the 20th cen-
tury, the number of rabbits on the pen-
insula has declined >90%, mainly be-
cause of diseases (1). The first notable 
crisis among rabbits occurred during 
the 1950s concurrent with the arrival 
of myxomatosis among rabbit popu-
lations, which caused mortality rates 
of ≈90% (1), as registered in other 
regions. During the late 1980s, a cali-
civirus, RHDV, caused infections that 
made a strong impact on rabbit popu-
lations, causing initial mortality rates 
of 55%–75% in Iberia (1). Since their 
initial outbreaks, both diseases have 
become enzootic, and related mortality 
rates have decreased, in part because 
of increased host resistance, although 
the infections still play a major role in 
the dynamics of rabbit populations (2).
In 2011, a new variant of RHDV, 
which appears to be closely related to 
an isolate originating in France that 
was described in 2010 (3), caused 
high mortality rates in some rabbit 
farms in Spain (4) and was also iden-
tified in an experimental wild rab-
bit plot in northern Spain (5). Since 
2012, the new variant of RHDV has 
been detected in most rabbit farms in 
Spain (6), and in several wild popu-
lations distributed across Spain and 
Portugal (7), suggesting that it has 
rapidly spread throughout the Iberian 
Peninsula. This variant affects both of 
the wild rabbit subspecies (O. cunicu-
lus cuniculus and O. c. algirus), and 
unlike the classical form of RHDV, it 
kills rabbits as young as 11 days of 
age and rabbits that have been vac-
cinated against classic RHDV (6,7). 
This scenario has raised concern for 
the survival of wild rabbit popula-
tions and its predators in this region.
Data regarding rabbit trends seem 
to sustain this concern. For example, 
a long-term monitoring program in 
Aragón in northern Spain shows a no-
table decline in rabbit numbers during 
2013 in populations that showed both 
long-term increasing and decreas-
ing trends over the monitoring period 
(Figure, panels A, B, respectively). 
A similar trend has been observed in 
the main areas inhabited by the highly 
endangered Iberian lynx (Lynx pardi-
nus). The lynx relies on rabbits for 
survival, because they represent >85% 
of the lynx’s diet (9). For instance, in 
Coto del Rey, the area within Doñana 
National Park in southern Spain that 
traditionally held the highest rabbit 
densities and therefore represents the 
core of Iberian lynx populations in 
this national park, there was a decline 
in rabbits of >80% during 2012–2013 
(Figure, panel C). Similar declines 
have been detected in low-density 
rabbit populations surveyed within 
Doñana National Park (Figure, panel 
C). Rabbit numbers have also been 
progressively dropping in the prox-
imity of the Yeguas River in Andújar 
and Cardeña Natural Parks in south-
ern Spain, where the largest Iberian 
lynx population currently lives: rab-
bit density was >3.5 rabbits/hectare in 
2010 and <1 rabbit/hectare in 2013, a 
decline of ≈75% (10). In accordance 
with field surveys, hunters throughout 
Iberia claim that the number of rabbits 
harvested this season has decreased 
dramatically, pointing to a 70%–80% 
decline compared to the previous 
hunting season in some estates (A. Li-
nares, pers. comm.).
The European rabbit is a multi-
functional keystone species of the Ibe-
rian Mediterranean ecosystem, where 
it serves as prey for >30 predatory ani-
mals, alters plant species composition 
and vegetation structure through graz-
ing and seed dispersal, its excrement 
and urine have an effect on soil fertil-
ity and plant growth and provide feed-
ing resources for invertebrates, and its 
burrows provide shelter for different 
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